Novel platform technologies and instrumentation for on-demand detection of multiple health markers

Diagnostic tools to augment existing MCMs

Addressing acute respiratory distress syndrome (ARDS)

Covering a broad range of unmet critical needs outside the scopes of existing BARDA DRIVe initiatives

Manufacturing technologies/systems for vaccine production/distribution at or near point of service

Evaluating existing therapeutics as MCMs against filoviruses

Repurposing and advancing innovations against rad/nuc threats.